Key signalling factors and pathways in the molecular determination of skeletal muscle phenotype

Animal

Volumn 1, Issue 5, 2007, Pages 681-698

  Chang, K C ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Hyperplasia; Hypertrophy; Meat quality; Muscle fibres; Skeletal muscle

Indexed keywords

CALCINEURIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE;

ARTICLE; DNA MICROARRAY; FARM ANIMAL; FUNCTIONAL GENOMICS; GENE EXPRESSION; GENE IDENTIFICATION; MOLECULAR BIOLOGY; MOLECULAR INTERACTION; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE CONTRACTILITY; MUSCLE HYPERTROPHY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTEOMICS; REGULATOR GENE; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

ANIMALIA;

EID: 34249081419     PISSN: 17517311     EISSN: 1751732X     Source Type: Journal    
DOI: 10.1017/S1751731107702070     Document Type: Article

References (190)

1. Adams GR 2002. Autocrine and/or paracrine insulin-like growth factor-I activity in skeletal muscle. Clinical Orthopaedics and Related Research 403S, S188-S196.
2. Akimoto T, Pohnert SC, Li P, Zhang M, Gumbs C, Rosenberg PB, Williams RS and Yan Z 2005. Exercise stimulates Pgc-1α transcription in skeletal muscle through activation of the p38 MAPK pathway. Journal of Biological Chemistry 280, 19587-19593.
3. Artaza JN, Bhasin S, Magee TR, Reisz-Porszasz S, Shen R, Groome NP, Fareez MM and Gonzalez-Cadavid NF 2005. Myostatin inhibits myogenesis and promotes adipogenesis in C3H 10T(1/2) mesenchymal multipotent cells. Endocrinology 146, 3547-3557.
4. Asakura A 2003. Stem cells in adult skeletal muscle. Trends in Cardiovascular Medicine 13, 123-128.
5. Awede BL, Thissen JP and Lebacq J 2002. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. AJP - Endocrinology and Metabolism 282, E31-E37.
6. Balasubramanian S and Kuppuswamy D 2003. RGD-containing peptides activate S6K1 through β3 integrin in adult cardiac muscle cells. Journal of Biological Chemistry 278, 42214-42224.
7. Bancroft JD and Gamble M 2002. Theory and practice of histological techniques. Churchill Livingston, London.
8. Barton-Davis ER, Shoturma DI, Musaro A, Rosenthal N and Sweeney HL 1998. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proceedings of the National Academy of Sciences USA 95, 15603-15607.
9. Bass J, Oldham J, Sharma M and Kambadur R 1999. Growth factors controlling muscle development. Domestic Animal Endocrinology 17, 191-197.
10. Baxendale S, Davison C, Muxworthy C, Wolff C, Ingham W and Roy S 2004. The B-cell maturation factor Blimp-1 specifies vertebrate slow-twitch muscle fiber identity in response to Hedgehog signaling. Nature Genetics 36, 88-93.
11. Beuzen ND, Stear MJ and Chang KC 2000. Molecular markers and their use in animal breeding. Veterinary Journal 160, 42-52.
12. Bigard X, Sanchez H, Zoll J, Mateo P, Rousseau V, Veksler V and Ventura-Clapier R 2000. Calcineurin co-regulates contractile and metabolic components of slow muscle phenotype. Journal of Biological Chemistry 275, 19653-19660.
13. Blanco A, Artacho-Perula E, Flores-Acuna R, Moyano R and Monterde JG 2003. Quantitative changes in the normal and apoptotic thymocytes of pigs treated with anabolic doses of the β2 adrenergic agonist clenbuterol. Veterinary Immunology and Immunopathology 96, 111-115.
14. Blanco A, Flores-Acuna F, Roldan-Villalobos R and Monterde JG 2002. Testicular damage from anabolic treatments with the β2-adrenergic agonist clenbuterol in pigs: a light and electron microscope study. Veterinary Journal 163, 292-298.
15. Bodine SC, Latres E, Baumhueter S, Lai VKM, Nunez L, Clarke BA, Poueymirou WT, Panaro FJ, Na E, Dharmarajan K, Pan Z-Q, Valenzuela DM, DeChiara TM, Stitt TN, Yancopoulos GD and Glass DJ 2001a. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294, 1704-1708.
16. Bodine SC, Stitt TN, Gonzalez M, Kline WO, Stover GL, Bauerlein R, Zlotchenko E, Scrimgeour A, Lawrence JC, Glass DJ and Yancopoulos GD 2001b. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nature Cell Biology 3, 1014-1019.
17. Bouley J, Meunier B, Chambon C, De Smet S, Hocquette JF and Picard B 2006. Proteomic analysis of bovine skeletal muscle hypertrophy. Proteomics 5, 490-500.
18. Brooke MH and Kaiser KK 1970. Muscle fiber types: how many and what kind? Archives of Neurology 23, 369-379.
19. Buckingham M 2001. Skeletal muscle formation in vertebrates. Current Opinion in Genetics & Development 11, 440-448.
20. Buckingham M, Bajard L, Chang T, Daubas P, Hadchouel J, Meilhac S, Montarras D, Rocancourt D and Relaix F 2003. The formation of skeletal muscle: from somite to limb. Journal of Anatomy 202, 59-68.
21. Bueno OF, Van Rooij E, Molkentin JD, Doevendans PA and De Windt LJ 2002. Calcium and hypertrophic heart disease: novel insights and remaining questions. Cardiovascular Research 53, 806-821.
22. Burgering BMT and Medema RH 2004. Decisions on life and death: FOXO forkhead transcription factors are in command when PKB/Akt is off duty. Journal of Leukocyte Biology 73, 689-701.
23. Burniston JG, Ng Y, Clark WA, Colyer J, Tan LB and Goldspink DF 2002. Myotoxic effects of clenbuterol in the rat heart and soleus muscle. Journal of Applied Physiology 93, 1824-1832.
24. Byrne KA, Wang YH, Lehnert SA, Harper GS, McWilliam SM, Bruce HL and Reverter A 2005. Gene expression profiling of muscle tissue in Brahman steers during nutritional restriction. Journal of Animal Science 83, 1-12.
25. Cabane C, Englaro W, Yeow K, Ragno M and Derijard B 2003. Regulation of C2C12 myogenic terminal differentiation by MKK3/p38α pathway. American Journal of Physiology -Cell Physiology 284, C658-C666.
26. Caiozzo VJ 2004. Plasticity of skeletal muscle phenotype: mechanical consequences. Muscle Nerve 26, 740-768.
27. Caiozzo VJ, Baker MJ, McCue SA and Baldwin KM 1997. Single-fiber and whole muscle analyses of MHC isoform plasticity: interaction between T3 and unloading. American Journal of Physiology -Cell Physiology 273, C944-C952.
28. Cao X, Kambe F, Miyazaki T, Sarkar D, Ohmori S and Seo H 2002. Novel human ZAKI-4 isoforms: hormonal and tissue-specific regulation and function as calcineurin inhibitors. Biochemical Journal 367, 459-466.
29. Casser-Malek I, Hocquette JF, Jurie C, Listrat A, Jailler R, Bauchart D, Briand Y and Picard B 2004. Muscle-specific metabolic, histochemical and biochemical responses to a nutritionally induced discontinuous growth path. Animal Science 79, 49-59.
30. Centner T, Yano J, Kimura E, McElhinny AS, Pelin K, Witt CC, Bang ML, Trombitas K, Granzier H and Gregorio CC 2001. Identification of muscle specific ring finger proteins as potential regulators of the titin kinase domain. Journal of Molecular Biology 306, 717-726.
31. Chang KC, Da Costa N, Blackley R, Southwood O, Evans G, Plastow G, Wood JD and Richardson RI 2003. Relationships of myosin heavy chain fibre types to meat quality traits in traditional and modern pigs. Meat Science 64, 93-103.
32. Chang KC and Fernandes K 1997. Developmental expression and 5′ end cDNA cloning of the porcine 2x and 2b myosin heavy chain genes. DNA and Cell Biology 16, 1429-1437.
33. Chang KC, Fernandes K and Dauncey MJ 1995. Molecular characterization of a developmentally regulated porcine skeletal myosin heavy chain gene and its 5′ regulatory region. Journal of Cell Science 108, 1779-1789.
34. Chang KC, Fernandes K and Goldspink G 1993. In vivo expression and molecular characterization of the porcine slow-myosin heavy chain. Journal of Cell Science 106, 331-341.
35. Charge SBP, Brack AS and Hughes SM 2002. Aging-related satellite cell differentiation defect occurs prematurely after Ski-induced muscle hypertrophy. American Journal of Physiology -Cell Physiology 283, C1228-C1241.
36. Chen Y, Zajac JD and MacLean HE 2005. Androgen regulation of satellite cell function. Journal of Endocrinology 186, 21-31.
37. Chikuni K, Muroya S and Nakajima I 2004. Absence of the functional myosin heavy chain 2b isoform in equine skeletal muscles. Zoological Science 21, 589-596.
38. Clement K, Viguerie N, Diehn M, Alizadeh A, Barbe P, Thalamas C, Storey JD, Brown PO, Barsh GS and Langin D 2002. In vivo regulation of human skeletal muscle gene expression by thyroid hormone. Genome Research 12, 281-291.
39. Conejo R, Valverde AM, Benito M and Lorenzo M 2001. Insulin produces myogenesis in C2C12 myoblasts by induction of NF-κB and downregulation of AP-1 activities. Journal of Cellular Physiology 186, 82-94.
40. Coolican SA, Samuel DS, Ewton DZ and McWade FJ 1997. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways. Journal of Biological Chemistry 272, 6653-6662.
41. Costelli P, Carbo N, Busquets S, Lopez-Soriano FJ, Baccino FM and Argiles JM 2003. Reduced protein degradation rates and low expression of proteolytic systems support skeletal muscle hypertrophy in transgenic mice overexpressing the c-ski oncogene. Cancer Letters 200, 153-160.
42. Crabtree GR 2001. Calcium, calcineurin, and the control of transcription. Journal of Biological Chemistry 276, 2313-2316.
43. Da Costa N, McGillivray C, Bai Q, Wood JD, Evans G and Chang KC 2004. Energy and protein restriction induces molecular changes in young porcine skeletal muscles. Journal of Nutrition 134, 2191-2199.
44. Da Costa N, McGillivray C and Chang KC 2003. Postnatal myosin heavy chain isoforms in prenatal porcine skeletal muscles: insights into temporal regulation. Anatomical Record 273A 731-740.
45. Dehoux MJM, Van Beneden RP, Fernandez-Celemin L, Lause PL and Thissen JP 2003. Induction of MafBx and Murf ubiquitin ligase mRNAs in rat skeletal muscle after LPS injection. FEBS Letters 544, 214-217.
46. Delling U, Tureckova J, Lim HW, De Windt LJ, Rotwein P and Molkentin JD 2000. A calcineurin-NFATc3-dependent pathway regulates skeletal muscle differentiation and slow myosin heavy-chain expression. Molecular and Cellular Biology 20, 6600-6611.
47. Denley A, Cosgrove LJ, Booker GW, Wallace JC and Forbes BE 2005. Molecular interactions of the IGF system. Cytokine & Growth Factor Reviews 16, 421-439.
48. Doumit ME, Cook DR and Merkel RA 1996. Testosterone up-regulates androgen receptors and decreases differentiation of porcine myogenic satellite cells in-vitro. Endocrinology 137, 1385-1394.
49. Du M, Zhu MJ, Means WJ, Hess BW and Ford SP 2005. Nutrient restriction differentially modulates the mammalian target of rapamycin signaling and the ubiquitin-proteasome system in skeletal muscle of cows and their fetuses. Journal of Animal Science 83, 117-123.
50. Dunn SE, Simard AR, Bassel-Duby R, Williams RS and Michel RN 2001. Nerve activity-dependent modulation of calcineurin signaling in adult fast and slow skeletal muscle fibers. Journal of Biological Chemistry 276, 45243-45254.
51. Dunshea FR, D'Souza DN, Pethick DW, Harper GS and Warner RD 2005. Effects of dietary factors and other metabolic modifiers on quality and nutritional value of meat. Meat Science 71, 8-38.
52. Dwyer CM, Stickland NC and Fletcher JM 1994. The influence of maternal nutrition on muscle fiber number development in the porcine fetus and on subsequent postnatal growth. Journal of Animal Science 72, 911-917.
53. Erbay E and Chen J 2001. The mammalian target of rapamycin regulates C2C12 myogenesis via a kinase-independent mechanism. Journal of Biological Chemistry 276, 36079-36082.
54. Erbay E, Park IH, Nuzzi PD, Schoenherr CJ and Chen J 2003. IGF-II transcription in skeletal myogenesis is controlled by mTOR and nutrients. Journal of Cell Biology 163, 931-936.
55. Espinosa L, Ingles-Esteve J, Aguilera C and Bigas A 2003. Phosphorylation by glycogen synthase kinase-3β down-regulates notch activity, a link for notch and Wnt pathways. Journal of Biological Chemistry 278, 32227-32235.
56. Essén-Gustavsson B 1993. Muscle-fiber characteristics in pigs and relationships to meat-quality parameters- review. In Pork quality: genetic and metabolic factors (ed. E Puolanne and DI Demeyer), pp. 140-159, CAB International, Wallingford UK.
57. Fang SH, Nishimura T and Takahashi K 1999. Relationship between development and intramuscular connective tissue and toughness of pork during growth of pigs. Journal of Animal Science 77, 120-130.
58. Fraysse B, Desaphy JF, Pierno S, De Luca A, Liantonio A, Mitolo CI and Camerino DC 2003. Decrease in resting calcium and calcium entry associated with slow-to-fast transition in unloaded rat soleus muscle. FASEB Journal 17, 1916-1918.
59. Fujiwara Y, Chang AN, Williams AM and Orkin SH 2004. Functional overlap of GATA-1 and GATA-2 in primitive hematopoietic development. Blood 103, 583-585.
60. Geay Y, Bauchart D, Hocquette J-F and Culioli J 2001. Effect of nutritional factors on biochemical, structural and metabolic characteristics of muscles in ruminants, consequences on dietetic value and sensorial qualities of meat. Reproduction Nutrition Development 41, 1-26.
61. Gil F, Lopez-Albors O, Vazquez JM, Latorre R, Ramirez-Zarzosa G and Moreno F 2001. The histochemical profiles of fibre types in porcine skeletal muscle. Histology and Histopathology 16, 439-442.
62. Giles RH, Van Es JH and Clevers H 2003. Caught up in a Wnt storm: Wnt signaling in cancer. Biochimica et Biophysica Acta -Reviews on Cancer 1653, 1-24.
63. Glass DJ 2003a. Molecular mechanisms modulating muscle mass. Trends in Molecular Medicine 9, 344-350.
64. Glass DJ 2003b. Signalling pathways that mediate skeletal muscle hypertrophy and atrophy. Nature Cell Biology 5, 87-90.
65. Glass DJ 2005. Skeletal muscle hypertrophy and atrophy signaling pathways. International Journal of Biochemistry & Cell Biology 37, 1974-1984.
66. Goldring K, Partridge T and Watt D 2002. Muscle stem cells. Journal of Pathology 197, 457-467.
67. Grobet L, Martin LJR, Poncelet D, Pirottin D, Brouwers B, Riquet J, Schoeberlein A, Dunner S, Ménissier F, Massabanda J, Fries R, Hanset R and Georges M 1997. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nature Genetics 17, 71-74.
68. Haddad F and Adams GR 2004. Inhibition of MAP/ERK kinase prevents IGF-I induced hypertrophy in rat muscles. Journal of Applied Physiology 96, 203-210.
69. Hallauer PL and Hastings KEM 2002. Coregulation of fast contractile protein transgene and glycolytic enzyme expression in mouse skeletal muscle. American Journal of Physiology -Cell Physiology 282, C113-C124.
70. Handschin C, Rhee J, Lin J, Tarr PT and Spiegelman BM 2003. An autoregulatory loop controls peroxisome proliferator-activated receptor γ coactivator 1α expression in muscle. Proceedings of the National Academy of Sciences USA 100, 7111-7116.
71. Hinkle RT, Hodge KMB, Cody DB, Sheldon RJ, Kobilka BK and Isfort RJ 2002. Skeletal muscle hypertrophy and anti-atrophy effects of clenbuterol are mediated by the β2-adrenergic receptor. Muscle Nerve 25, 729-734.
72. Hirai S, Matsumoto H, Hino N, Kawachi H, Matsui T and Yano H 2007. Myostatin inhibits differentiation of bovine preadipocyte. Domestic Animal Endocrinology 32, 1-14.
73. Hocquette JF, Ortigues-Marty I, Pethick D, Herpin P and Fernandez X 1998. Nutritional and hormonal regulation of energy metabolism in skeletal muscles of meat-producing animals. Livestock Production Science 56, 115-143.
74. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X and Grimaldi PA 2003. Nutritional regulation and role of peroxisome proliferator-activated receptor δ in fatty acid catabolism in skeletal muscle. Biochimica et Biophysica Acta 1633, 43-50.
75. Hornick JL, Van Eenaeme C, Gérard O, Dufrasne I and Istasse L 2000. Mechanisms of reduced and compensatory growth. Domestic Animal Endocrinology 19, 121-132.
76. Horsley V, Jansen KM, Mills ST and Pavlath GK 2003. IL-4 acts as a myoblast recruitment factor during mammalian muscle growth. Cell 113, 483-494.
77. Horsley V and Pavlath GK 2002. NFAT: ubiquitous regulator of cell differentiation and adaptation. Journal of Cell Biology 156, 771-774.
78. Ji SQ, Losinski RL, Cornelius SG, Frank GR, Willis GM, Gerrard DE, Depreux FS and Spurlock ME 1998. Myostatin expression in porcine tissues: tissue specificity and developmental and postnatal regulation. American Journal of Physiology -Regulatory Integrative and Comparative Physiology 44, R1265-R1273.
79. Jiang BH, Zheng JZ and Vogt PK 1998. An essential role of phosphatidylinositol 3-kinase in myogenic differentiation. Proceedings of the National Academy of Sciences USA 95, 14179-14183.
80. Jope RS 2003. Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes. Trends in Pharmacological Sciences 24, 441-443.
81. Kamanga-Sollo E, Pampusch MS, White ME and Dayton WR 2003. Role of insulin-like growth factor binding protein (IGFBP)-3 in TGF-β and GDF-8 (myostatin)-induced suppression of proliferation in porcine embryonic myogenic cell cultures. Journal of Cellular Physiology 197, 225-231.
82. Kambadur R, Sharma M, Smith TL and Bass JJ 1997. Mutations in myostatin (GDF8) in double-muscled Belgian blue and Piedmontese cattle. Genome Research 7, 910-916.
83. Karlsson AH, Klont RE and Fernandez X 1999. Skeletal muscle fibres as factors for pork quality. Livestock Production Science 60, 255-269.
84. Kelley DE, Goodpaster BH and Storlien L 2002. Muscle triglyceride and insulin resistance. Annual Review of Nutrition 22, 325-346.
85. Kirk SP, Oldham JM, Jeanplong F and Bass JJ 2003. Insulin-like growth factor-II delays early but enhances late regeneration of skeletal muscle. Journal of Histochemistry and Cytochemistry 51, 1611-1620.
86. Klont RE, Brocks L and Eikelenboom G 1998. Muscle fibre type and meat quality. Meat Science 49, S219-S229.
87. Kocamis H and Killefer J 2002. Myostatin expression and possible functions in animal muscle growth. Domestic Animal Endocrinology 23, 447-454.
88. Koh EH, Kim M-S, Park J-T, Kim HS, Youn J-Y, Park H-S, Youn JH and Lee K-U 2003. Peroxisome proliferator-activated receptor (PPAR)-α activation prevents diabetes in OLETF rats: comparison with PPAR-γ activation. Diabetes 52, 2331-2337.
89. Kutscher EC, Luna BC and Perry PJ 2002. Anabolic steroids: a review for the clinician. Sports Medicine 32, 285-296.
90. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S and Kambadur R 2002. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. Journal of Biological Chemistry 277, 49831-49840.
91. LaVoie HA 2003. The role of GATA in mammalian reproduction. Experimental Biology and Medicine 228, 1282-1290.
92. Lecker SH, Jagoe RT, Gilbert A, Gomes M, Baracos V, Bailey J, Price SR, Mitch WE and Goldberg AL 2004. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. FASEB Journal 18, 39-51.
93. Lee J, Hong F, Kwon S, Kim SS, Ki DO, Kang HS, Lee SJ, Ha J and Kim SS 2002. Activation of p38 MAPK induces cell cycle arrest via inhibition of Raf/ERK pathway during muscle differentiation. Biochemical and Biophysical Research Communications 298, 765-771.
94. Lefaucheur L, Milan D, Eolan P and Le Callennec C 2004. Myosin heavy chain composition of different skeletal muscles in Large White and Meishan pigs. Journal of Animal Science 82, 1931-1941.
95. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL and Reid MB 2005. TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB Journal 19, 362-370.
96. Li YP, Chen Y, Li AS and Reid MB 2003. Hydrogen peroxide stimulates ubiquitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. American Journal of Physiology -Cell Physiology 285, C806-C812.
97. Lin J, Wu H, Tarr PT, Zhang CY, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, Lowell BB, Bassel-Duby R and Spiegelman BM 2002. Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres. Nature 418, 797-801.
98. Liu W, Thomas SG, Asa SL, Gonzalez-Cadavid N, Bhasin S and Ezzat S 2003. Myostatin is a skeletal muscle target of growth hormone anabolic action. Journal of Clinical Endocrinology and Metabolism 88, 5490-5496.
99. Liu Y, Cseresnyés Z, Randall WR and Schneider MF 2001. Activity-dependent nuclear translocation and intranuclear distribution of NFATc in adult skeletal muscle fibers. Journal of Cell Biology 155, 27-40.
100. Lynch GS, Cuffe SA, Plant DR and Gregorevic P 2001. IGF-I treatment improves the functional properties of fast- and slow-twitch skeletal muscles from dystrophic mice. Neuromuscular Disorders 11, 260-268.
101. Maak S, Jaesert S, Neumann K, Yerle M and Von Lengerken G 2001. Isolation of expressed sequence tags of skeletal muscle of neonatal healthy and splay leg piglets and mapping by somatic cell hybrid analysis. Animal Genetics 32, 303-307.
102. MacAulay K, Hajduch E, Blair AS, Coghlan MP, Smith SA and Hundal HS 2003. Use of lithium and SB-415286 to explore the role of glycogen synthase kinase-3 in the regulation of glucose transport and glycogen synthase. European Journal of Biochemistry 270, 3829-3838.
103. McCormick RJ 1999. Extracellular modifications to muscle collagen: implications for meat quality. Poultry Science 78, 785-791.
104. McCroskery S, Thomas M, Maxwell L, Sharma M and Kambadur R 2003. Myostatin negatively regulates satellite cell activation and self-renewal. Journal of Cell Biology 162, 1135-1147.
105. McPherron AC and Lee SJ 1997. Double muscling in cattle due to mutations in the myostatin gene. Proceedings of the National Academy of Sciences USA 94, 12457-12461.
106. Maccatrozzo L, Patruno M, Toniolo L, Reggiani C and Mascarello F 2004. Myosin heavy chain 2B isoform is expressed in specialized eye muscles but not in trunk and limb muscles of cattle. European Journal of Histochemistry 48, 357-366.
107. Maltin C, Balcerzak D, Tilley R and Delday M 2003. Determinants of meat quality: tenderness. Proceedings of the Nutrition Society 62, 337-347.
108. Marchitelli C, Savarese MC, Crisa A, Nardone A, Marsan PA and Valentini A 2003. Double muscling in Marchigiana beef breed is caused by a stop codon in the third exon of myostatin gene. Mammalian Genome 14, 392-395.
109. Martin B, Schneider R, Janetzky S, Waibler Z, Pandur P, Kuhl M, Behrens J, der Mark K, Starzinski-Powitz A and Wixler V 2002. The LIM-only protein FHL2 interacts with β-catenin and promotes differentiation of mouse myoblasts. Journal of Cell Biology 159, 113-122.
110. Masuda ES, Imamura R, Amasaki Y, Arai K and Arai N 1998. Signalling into the T-cell nucleus: NFAT regulation. Cellular Signalling 10, 599-611.
111. Mersmann HJ 1998. Overview of the effects of β-adrenergic receptor agonists on animal growth including mechanisms of action. Journal of Animal Science 76, 160-172.
112. Mills SE, Spurlock ME and Smith DJ 2003. β-Adrenergic receptor subtypes that mediate ractopamine stimulation of lipolysis. Journal of Animal Science 81, 662-668.
113. Mitin N, Kudla AJ, Konieczny SF and Taparowsky EJ 2001. Differential effects of Ras signaling through NFκB on myogenesis. Oncogene 20, 1276-1286.
114. Miura S, Kai Y, Ono M and Ezaki O 2003. Overexpression of peroxisome proliferator-activated receptor γ coactivator-1α down-regulates GLUT4 mRNA in skeletal muscles. Journal of Biological Chemistry 278, 31385-31390.
115. Morali OG, Jouneau A, McLaughlin KJ, Thiery JP and Larue L 2000. IGFII promotes mesoderm formation. Developmental Biology 227, 133-145.
116. Morio B, Hocquette JF, Montaurier C, Boirie Y, Bouteloup-Demange C, McCormack C, Fellmann N, Beaufrere B and Ritz P 2001. Muscle fatty acid oxidative capacity is a determinant of whole body fat oxidation in elderly people. American Journal of Physiology - Endocrinology and Metabolism 280, E143-E149.
117. Muoio DM, Way JM, Tanner CJ, Winegar DA, Kliewer SA, Houmard JA, Kraus WE and Dohm GL 2002. Peroxisome proliferator-activated receptor-a regulates fatty acid utilization in primary human skeletal muscle cells. Diabetes 51, 901-909.
118. Murgia M, Serrano AL, Calabria E, Pallafacchina G, Lømo T and Schiaffino S 2000. Ras is involved in nerve-activity-dependent regulation of muscle genes. Nature Cell Biology 2, 142-147.
119. Musarò A, McCullagh JA, Naya FJ, Olson EN and Rosenthal N 1999. IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1. Nature 400, 581-585.
120. Musarò A, McCullagh K, Paul A, Houghton L, Dobrowolny G, Molinaro M, Barton ER, Sweeney HL and Rosenthal N 2001. Localized Igf-1 transgene expression sustains hypertrophy and regeneration in senescent skeletal muscle. Nature Genetics 27, 195-200.
121. Naya FJ, Mercer B, Shelton J, Richardson JA, Williams RS and Olson EN 2000. Stimulation of slow skeletal muscle fiber gene expression by calcineurin in vivo. Journal of Biological Chemistry 275, 4545-4548.
122. Naya FJ and Olson E 1999. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Current Opinion in Cell Biology 11, 683-688.
123. Nissen PM, Danielsen VO, Jorgensen PF and Oksbjerg N 2003. Increased maternal nutrition of sows has no beneficial effects on muscle fiber number or postnatal growth and has no impact on the meat quality of the offspring. Journal of Animal Science 81, 3018-3027.
124. Novak A and Dedhar S 1999. Signaling through β-catenin and Lef/Tcf. Cellular and Molecular Life Sciences 56, 523-537.
125. Oberkofler H, Esterbauer H, Linnemayr V, Strosberg AD, Krempler F and Patsch W 2002. Peroxisome proliferator-activated receptor (PPAR) γ coactivator-1 recruitment regulates PPAR subtype specificity. Journal of Biological Chemistry 277, 16750-16757.
126. Oka A, Iwaki F, Dohgo T, Ohtagaki S, Noda M, Shiozaki T, Endoh O and Ozaki M 2002. Genetic effects on fatty acid composition of carcass fat of Japanese Black Wagyu steers. Journal of Animal Science 80, 1005-1011.
127. Ooi PT, Da Costa N, Edgar J and Chang KC 2006. Porcine congenital splayleg is characterised by muscle fibre atrophy associated with relative rise in MAFbx and fall in P311 expression. BMC Veterinary Research 2, 23.
128. Pallafacchina G, Calabria E, Serrano AL, Kalhovde JM and Schiaffino S 2002. A protein kinase B-dependent and rapamycin-sensitive pathway controls skeletal muscle growth but not fiber type specification. Proceedings of the National Academy of Sciences USA 99, 9213-9218.
129. Parkington JD, Siebert AP, LeBrasseur NK and Fielding RA 2003. Differential activation of mTOR signaling by contractile activity in skeletal muscle. American Journal of Physiology -Regulatory Integrative and Comparative Physiology 285, R1086-R1090.
130. Paul AC and Rosenthal N 2002. Different modes of hypertrophy in skeletal muscle fibers. Journal of Cell Biology 156, 751-760.
131. Petropoulos H and Skerjanc IS 2002. β-Catenin is essential and sufficient for skeletal myogenesis in P19 Cells. Journal of Biological Chemistry 277, 15393-15399.
132. Pette D and Staron RS 2000. Myosins isoforms, muscle fiber types, and transitions. Microscopy Research and Technique 50, 500-509.
133. Philip B, Lu Z and Gao Y 2005. Regulation of GDF-8 signaling by the p38 MAPK. Cellular Signalling 17, 365-375.
134. Picard B, Gagniere H, Geay Y, Hocquette J-F and Robelin J 1995. Study of the influence of age and weaning on the contractile and metabolic characteristics of bovine muscle. Reproduction Nutrition Development 35, 71-84.
135. Picard B, Lefaucheur L, Berri C and Duclos MJ 2002. Muscle fibre ontogenesis in farm animal species. Reproduction Nutrition Development 42, 415-431.
136. Polesskaya A, Seale P and Rudnicki MA 2003. Wnt signaling induces the myogenic specification of resident CD45 + adult stem cells during muscle regeneration. Cell 113, 841-852.
137. Prunier C, Pessah M, Ferrand N, Seo SR, Howe P and Atfi A 2003. The oncoprotein Ski acts as an antagonist of transforming growth factor-β signaling by suppressing Smad2 phosphorylation. Journal of Biological Chemistry 278, 26249-26257.
138. Rao A, Luo C and Hogan PG 1997. Transcription factors of the NFAT family:regulation and function. Annual Review of Immunology 15, 707-747.
139. Rehfeldt C, Kuhn G, Vanselow J, Fürbass R, Fiedler I, Nürnberg G, Clelland AK, Stickland NC and Ender K 2001. Maternal treatment with somatotropin during early gestation affects basic events of myogenesis in pigs. Cell and Tissue Research 306, 429-440.
140. Relaix F 2006. Skeletal muscle progenitor cells: from embryo to adult. Cellular and Molecular Life Sciences 63, 1221-1225.
141. Rommel C, Bodine SC, Clarke BA, Rossman R, Nunez L, Stitt TN, Yancopoulos GD and Glass DJ 2001. Mediation of IGF-1-induced skeletal myotube hypertrophy by PI(3)K/Akt/mTOR and PI(3)K/Akt/GSK3 pathways. Nature Cell Biology 3, 1009-1013.
142. Rommel C, Clarke BA, Zimmermann S, Nuñez L, Rossman R, Reid K, Moelling K, Yancopoulos GD and Glass DJ 1999. Differentiation stage-specific inhibition of the Raf-MEK-ERK pathway by Akt. Science 286, 1738-1744.
143. Rothermel BA, McKinsey TA, Vega RB, Nicol RL, Mammen P, Yang J, Antos CL, Shelton JM, Bassel-Duby R, Olson EN and Williams RS 2001. Myocyteenriched calcineurin-interacting protein, MCIP1, inhibits cardiac hypertrophy in vivo. Proceedings of the National Academy of Sciences USA 98, 3328-3333.
144. Ryall JG, Gregorevic P, Plant DR, Sillence MN and Lynch GS 2002. β2-Agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol. American Journal of Physiology -Regulatory Integrative and Comparative Physiology 283, R1386-R1394.
145. Sakamoto K, Aschenbach WG, Hirshman MF and Goodyear LJ 2003. Akt signaling in skeletal muscle: regulation by exercise and passive stretch. American Journal of Physiology - Endocrinology and Metabolism 285, E1081-E1088.
146. Sakuma K, Nishikawa J, Nakao R, Watanabe K, Totsuka T, Nakano H, Sano M and Yasuhara M 2003. Calcineurin is a potent regulator for skeletal muscle regeneration by association with NFATc1 and GATA-2. Acta Neuropathologica 105, 271-280.
147. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH and Goldberg AL 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal atrophy. Cell 117, 399-412.
148. Sant'ana Pereira JA, Wessels A, Nijtmans L, Moorman AF and Sargeant AJ 1995. New method for the accurate characterization of single human skeletal muscle fibres demonstrates a relation between mATPase and MyHC expression in pure and hybrid fibre types. Journal of Muscle Research and Cell Motility 16, 21-34.
149. Schiaffino S and Reggiani C 1996. Molecular diversity of myofibrillar proteins: gene regulation and functional significance. Physiological Reviews 76, 371-423.
150. Schiaffino S and Reggiani C 1994. Myosin isoforms in mammalian skeletal muscle. Journal of Applied Physiology 77, 493-501.
151. Schulz RA and Yutzey KE 2004. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Developmental Biology 266, 1-16.
152. 2+-dependent calcineurin signalling pathway. Nature 400, 576-581.
153. Shi DL, Bourdelas A, Umbhauer M and Boucaut JC 2002. Zygotic Wnt/β-catenin signaling preferentially regulates the expression of Myf5 gene in the mesoderm of xenopus. Developmental Biology 245, 124-135.
154. Sillence MN, Munn KJ and Campbell RG 2002. Manipulation of growth in pigs through treatment of the neonate with clenbuterol and somatotropin. Journal of Animal Science 80, 1852-1862.
155. Sinha-Hikim I, Roth SM, Lee MI and Bhasin S 2003. Testosterone-induced muscle hypertrophy is associated with an increase in satellite cell number in healthy, young men. American Journal of Physiology - Endocrinology and Metabolism 285, E197-E205.
156. Soeta C, Suzuki M, Suzuki S, Naito K, Tachi C and Tojo H 2001. Possible role for the c-ski gene in the proliferation of myogenic cells in regenerating skeletal muscles of rats. Development Growth and Differentiation 43, 155-164.
157. Spangenburg EE and Booth FW 2003. Molecular regulation of individual skeletal muscle fibre types. Acta Physiologica Scandinavica 178, 413-424.
158. Steelman CA, Recknor JC, Nettleton D and Reecy JM 2006. Transcriptional profiling of myostatin-knockout mice implicates Wnt signaling in postnatal skeletal muscle growth and hypertrophy. FASEB Journal 20, 580-582.
159. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD and Glass DJ 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Molecular Cell 14, 395-403.
160. Sugiura T, Sio SO, Shuntoh H and Kuno T 2001. Molecular genetic analysis of the calcineurin signaling pathways. Cellular and Molecular Life Sciences 58, 278-288.
161. Sutrave P, Kelly AM and Hughes SH 1990. Ski can cause selective growth of skeletal muscle in transgenic mice. Genes and Development 4, 1462-1472.
162. Sutrave P, Leferovich JM, Kelly AM and Hughes SH 2000. The induction of
163. Swoap SJ, Hunter RB, Stevenson EJ, Felton HM, Kansagra NV, Lang JM, Esser KA and Kandarian SC 2000. The calcineurin-NFAT pathway and muscle fibertype gene expression. American Journal of Physiology -Cell Physiology 279, C915-C924.
164. Tajbakhsh S and Buckingham M 2000. The birth of muscle progenitor cells in the mouse: spatiotemporal considerations. Current Topics in Developmental Biology 228, 225-268.
165. Tesseraud S, Metayer S, Duchene S, Bigot K, Grizard J and Dupont J 2007. Regulation of protein metabolism by insulin: value of different approaches and animal models. Domestic Animal Endocrinology (in press).
166. Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J and Kambadur R 2000. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. Journal of Biological Chemistry 275, 40235-40243.
167. Ueki N and Hayman MJ 2003. Direct interaction of Ski with either Smad3 or Smad4 is necessary and sufficient for Ski-mediated repression of transforming growth factor-β signaling. Journal of Biological Chemistry 278, 32489-32492.
168. Van Rooij E, Doevendans PA, Crijns HJGM,, Heeneman S, Lips DJ, Van Bilsen M, Williams RS, Olson EN, Bassel-Duby R, Rothermel BA, De Windt LJ, et al, 2004. MCIP1 overexpression suppresses left ventricular remodeling and sustains cardiac function after myocardial infarction. Circulation Research 94, 18e-26.
169. Vollenweider P 2003. Insulin resistant states and insulin signaling. Clinical Chemistry and Laboratory Medicine 41, 1107-1119.
170. Vyas DR, Spangenburg EE, Abraha TW, Childs TE and Booth FW 2002. GSK-3β negatively regulates skeletal myotube hypertrophy. American Journal of Physiology -Cell Physiology 283, C545-C551.
171. Wang Y-X, Lee C-H, Tiep S, Yu RT, Ham J, Kang H and Evans RM 2003. Peroxisome-proliferator-activated receptor δ activates fat metabolism to prevent obesity. Cell 113, 159-170.
172. Weiss A and Leinwand LA 1996. The mammalian myosin heavy chain gene family. Annual Review of Cell and Developmental Biology 12, 417-439.
173. Wigmore PMC and Stickland NC 1983. Muscle development in large and small pig fetuses. Journal of Anatomy 2, 235-245.
174. Wilson EM, Hsieh MM and Rotwein P 2003. Autocrine growth factor signaling by insulin-like growth factor-II mediates MyoD-stimulated myocyte maturation. Journal of Biological Chemistry 278, 41109-41113.
175. Wolfe RR 2006. The underappreciated role of muscle in health and disease. American Journal of Clinical Nutrition 84, 475-482.
176. Wood JD, Enser M, Fisher AV, Nute GR, Richardson RI and Sheard PR 1999. Manipulating meat quality and composition. Proceedings of the Nutrition Society 58, 363-370.
177. Wood JD, Nute GR, Richardson RI, Whittington FM, Southwood O, Plastow G, Mansbridge R, da Costa N and Chang KC 2004. Effects of breed, diet and muscle on fat deposition and eating quality in pigs. Meat Science 67, 651-667.
178. Wood JD, Richardson RI, Nute GR, Fisher AV, Campo MM, Kasapidou E, Sheard PR and Enser M 2003. Effects of fatty acids on meat quality: a review. Meat Science 66, 21-32.
179. Wu G, Bazer FW, Wallace JM and Spencer TE 2006. Intrauterine growth retardation: implications for the animal sciences. Journal of Animal Science 84, 2316-2337.
180. Wu H, Naya FJ, McKinsey TA, Mercer B, Shelton JM, Chin ER, Simard AR, Michel RN, Bassel-Duby R, Olson EN and Williams RS 2000a. MEF2 responds to multiple calcium-regulated signals in the control of skeletal muscle fiber type. EMBO Journal 19, 1963-1973.
181. Wu H, Rothermel B, Kanatous S, Rosenberg P, Naya FJ, Shelton M, Hutcheson KA, DiMaio M, Olson EN, Bassel-Duby R and Williams RS 2001. Activation of MEF2 by muscle activity is mediated through a calcineurin-dependent pathway. EMBO Journal 20, 6414-6423.
182. Wu YZ, Crumley RL and Caiozzo VJ 2000b. Are hybrid fibers a common motif of canine laryngeal muscles?: single-fiber analyses of myosin heavy-chain isoform composition. Archives of Otolaryngology - Head and Neck Surgery 126, 865-873.
183. Wu Z, Woodring PJ, Bhakta KS, Tamura K, Wen F, Feramisco JR, Karin M, Wang JYJ and Puri PP 2000c. p38 and extracellular signal-regulated kinases regulate the myogenic program at multiple steps. Molecular and Cellular Biology 20, 3951-3964.
184. Yang J, Rothermel B, Vega RB, Frey N, McKinsey TA, Olson EN, Bassel-Duby R and Williams RS 2000. Independent signals control expression of the calcineurin inhibitory proteins MCIP1 and MCIP2 in striated muscles. Circulation Research 87, 61-68.
185. Yang SY and Goldspink G 2002. Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Letters 522, 156-160.
186. Yimlamai T, Dodd SL, Borst SE and Park S 2005. Clenbuterol induces muscle-specific attenuation of atrophy through effects on the ubiquitin-proteasome pathway. Journal of Applied Physiology 99, 71-80.
187. Yu YH, Liu BH, Mersmann HJ and Ding ST 2006. Porcine peroxisome proliferator-activated receptor γ induces transdifferentiation of myocytes into adipocytes. Journal of Animal Science 84, 2655-2665.
188. Zierath JR and Hawley JA 2006. Skeletal muscle fiber type: influence on contractile and metabolic properties. PLoS Biology 2, 1523-1527.
189. Zimmermann S and Moelling K 1999. Phosphorylation and regulation of Raf by Akt (protein kinase B). Science 286, 1741-1744.
190. Zorzano A, Kaliman P, Guma A and Palacin M 2003. Intracellular signals involved in the effects of insulin-like growth factors and neuregulins on myofibre formation. Cellular Signalling 15, 141-149.